Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

ENDRA Life Sciences (NDRA) Gross Profit (2016 - 2018)

ENDRA Life Sciences has reported Gross Profit over the past 3 years, most recently at $6174.0 for Q1 2018.

  • Quarterly Gross Profit changed N/A to $6174.0 in Q1 2018 from the year-ago period, while the trailing twelve-month figure was $6174.0 through Dec 2018, down 96.55% year-over-year, with the annual reading at $6174.0 for FY2018, 96.55% down from the prior year.
  • Gross Profit was $6174.0 for Q1 2018 at ENDRA Life Sciences, up from $3765.0 in the prior quarter.
  • Over five years, Gross Profit peaked at $279704.0 in Q4 2016 and troughed at $3765.0 in Q4 2017.
  • The 3-year median for Gross Profit is $6345.0 (2017), against an average of $92943.6.
  • The largest YoY upside for Gross Profit was 98.65% in 2017 against a maximum downside of 98.65% in 2017.
  • A 3-year view of Gross Profit shows it stood at $279704.0 in 2016, then plummeted by 98.65% to $3765.0 in 2017, then skyrocketed by 63.98% to $6174.0 in 2018.
  • Per Business Quant, the three most recent readings for NDRA's Gross Profit are $6174.0 (Q1 2018), $3765.0 (Q4 2017), and $168730.0 (Q3 2017).